NET Remedies #12 Flu Immune (King Bio) – microbial contamination (2018)
Class I: A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death
Class I recall indicates potential for serious health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
NET Remedies #12 Flu Immune Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4212-2
Brand
King Bio Inc.
Lot Codes / Batch Numbers
Lots: NR-010617L Exp. 01/20, NR-011216D Exp. 01/19, NR-021717G Exp. 10/19, NR-040417K Exp. 04/20, NR-061616K Exp. 06/19, NR-090115G Exp. 09/18, NR-090616K Exp. 09/19, NR-101416K Exp. 10/19, NR-120815D Exp. 12/18, NR-010318A Exp. 01/20, NR-020118N Exp. 02/20, NR-051618G Exp. 05/20
Products Sold
Lots: NR-010617L Exp. 01/20; NR-011216D Exp. 01/19; NR-021717G Exp. 10/19; NR-040417K Exp. 04/20; NR-061616K Exp. 06/19; NR-090115G Exp. 09/18; NR-090616K Exp. 09/19; NR-101416K Exp. 10/19; NR-120815D Exp. 12/18; NR-010318A Exp. 01/20; NR-020118N Exp. 02/20; NR-051618G Exp. 05/20
King Bio Inc. is recalling NET Remedies #12 Flu Immune Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4212-2 due to Microbial contamination. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Microbial contamination
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026